| A structural approach to selection bias MA Hernán, S Hernández-Díaz, JM Robins Epidemiology 15 (5), 615-625, 2004 | 2835 | 2004 |
| Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology MA Hernán, S Hernández-Díaz, MM Werler, AA Mitchell American journal of epidemiology 155 (2), 176-184, 2002 | 1510 | 2002 |
| Major congenital malformations after first-trimester exposure to ACE inhibitors WO Cooper, S Hernandez-Diaz, PG Arbogast, JA Dudley, S Dyer, ... New England Journal of Medicine 354 (23), 2443-2451, 2006 | 1422 | 2006 |
| Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn CD Chambers, S Hernandez-Diaz, LJ Van Marter, MM Werler, C Louik, ... New England Journal of Medicine 354 (6), 579-587, 2006 | 1112 | 2006 |
| Folic acid antagonists during pregnancy and the risk of birth defects S Hernández-Díaz, MM Werler, AM Walker, AA Mitchell New England journal of medicine 343 (22), 1608-1614, 2000 | 1095 | 2000 |
| Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s S Hernández-Díaz, LAG Rodríguez Archives of internal medicine 160 (14), 2093-2099, 2000 | 947 | 2000 |
| Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008 AA Mitchell, SM Gilboa, MM Werler, KE Kelley, C Louik, ... American journal of obstetrics and gynecology 205 (1), 51. e1-51. e8, 2011 | 916 | 2011 |
| Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study S Hernández-Díaz, S Toh, S Cnattingius Bmj 338, 2009 | 746 | 2009 |
| First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects C Louik, AE Lin, MM Werler, S Hernández-Díaz, AA Mitchell New England Journal of Medicine 356 (26), 2675-2683, 2007 | 647 | 2007 |
| Comparative safety of antiepileptic drugs during pregnancy S Hernández-Díaz, CR Smith, A Shen, R Mittendorf, WA Hauser, M Yerby, ... Neurology 78 (21), 1692-1699, 2012 | 633 | 2012 |
| Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses MA Hernán, BC Sauer, S Hernández-Díaz, R Platt, I Shrier Journal of clinical epidemiology 79, 70-75, 2016 | 601 | 2016 |
| COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries M Skjefte, M Ngirbabul, O Akeju, D Escudero, S Hernandez-Diaz, ... European journal of epidemiology 36, 197-211, 2021 | 535 | 2021 |
| Beyond the intention-to-treat in comparative effectiveness research MA Hernán, S Hernández-Díaz Clinical trials 9 (1), 48-55, 2012 | 495 | 2012 |
| Use of over-the-counter medications during pregnancy MM Werler, AA Mitchell, S Hernandez-Diaz, MA Honein American journal of obstetrics and gynecology 193 (3), 771-777, 2005 | 431 | 2005 |
| Antidepressant use in pregnancy and the risk of cardiac defects KF Huybrechts, K Palmsten, J Avorn, LS Cohen, LB Holmes, JM Franklin, ... New England Journal of Medicine 370 (25), 2397-2407, 2014 | 424 | 2014 |
| Increase in prescription opioid use during pregnancy among Medicaid-enrolled women RJ Desai, S Hernandez-Diaz, BT Bateman, KF Huybrechts Obstetrics & Gynecology 123 (5), 997-1002, 2014 | 403 | 2014 |
| Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs LAG Rodríguez, S Hernández-Díaz Epidemiology 12 (5), 570-576, 2001 | 398 | 2001 |
| The birth weight “paradox” uncovered? S Hernández-Díaz, EF Schisterman, MA Hernán American journal of epidemiology 164 (11), 1115-1120, 2006 | 393 | 2006 |
| Development of a comorbidity index for use in obstetric patients BT Bateman, JM Mhyre, S Hernandez-Diaz, KF Huybrechts, MA Fischer, ... Obstetrics & Gynecology 122 (5), 957-965, 2013 | 373 | 2013 |
| Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies LAG Rodrı´ guez, Sonia Hernández‐Dı´ az, FJ De Abajo British journal of clinical pharmacology 52 (5), 563-571, 2001 | 373 | 2001 |
